SEATTLE–(BUSINESS WIRE)– #AGBT2024–NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString” or the “Company”), a leading provider of life science tools for discovery and translational research, today announced that it has reached an agreement with Patient Square Capital (“Patient Square”), a prominent health care investment firm, pursuant to which Patient Square will serve as the “stalking horse” bidder in conjunction with a court-supervised sales process. Under the terms of the agreement, Patient Squar
Business Wire Merger/Acquisition News
